Wrongful Death From a Defective Product or Drug

When a death is linked to a product or drug already at the center of a mass tort, families are dealing with two overlapping systems at once: the ordinary wrongful death framework, and whatever litigation already exists against that manufacturer. Neither one replaces the other, and one specific deadline — a statute of repose — trips up families in this situation more than almost any other type of wrongful death claim.

Quick answer: A death linked to a defective product or drug generally supports the same two claims as any wrongful death — a wrongful death claim for survivors’ losses and a survival action for the decedent’s own damages — filed by whoever has standing under your state’s law, typically the estate’s personal representative. If an MDL already exists for that product, the case is usually coordinated there. Beyond the ordinary wrongful death deadline, product claims can carry a separate statute of repose — an absolute cutoff from the product’s first sale, regardless of when the death occurred — that some states don’t waive even for toxic exposure cases.

Two Claims, One Additional System

The underlying legal structure here is the same as any wrongful death case: a wrongful death claim for what survivors lost, and a survival action for what the decedent themselves would have been entitled to — their own pain, suffering and medical expenses before death. Our wrongful death settlement amounts guide covers how both are valued and who has standing to bring them; that framework doesn’t change here.

What’s different is that the defendant may already be facing thousands of similar claims consolidated in a multidistrict litigation. If so, a new case is typically filed and then transferred into the existing MDL for coordinated pretrial handling — see our explainer on how mass tort litigation actually works for what that process actually involves, including why “the MDL settled” and “your specific case is resolved” are not automatically the same fact.

The Statute of Repose Trap

An ordinary wrongful death claim runs on a statute of limitations measured from the date of death. Product liability claims can carry an additional, harsher deadline: a statute of repose, an absolute outer limit measured from when the product was first sold — not from the injury, not from the diagnosis, and not from the death. A product sold decades before a death can, in some states, be entirely outside the repose period by the time anyone discovers the connection, regardless of how recently the death occurred.

Some states carve out exceptions for asbestos or certain toxic-exposure claims specifically, recognizing that these injuries can take decades to manifest — but this exception is not universal, and assuming your state has one without checking is a real risk. This is a meaningfully different, and often overlooked, deadline compared to the ordinary statute of limitations that governs most injury and death claims.

If the Case Was Already in Progress

Where the deceased was already a plaintiff — including a bellwether case — before their death, the lawsuit generally doesn’t automatically end. The estate’s personal representative typically needs to be formally substituted as the plaintiff to continue the case. This is a procedural step handled by counsel already in the litigation, but it’s worth confirming has actually happened rather than assuming it occurs on its own, particularly in a large MDL where individual case management can lag behind the headline settlement news.

Which Current Litigations Involve This

Several mass torts covered on this site involve conditions serious enough to result in death in some cases:

• Talcum powder litigation — ovarian cancer and, on a separate track, mesothelioma claims. See our talcum powder settlement status guide.
• Roundup/glyphosate litigation — non-Hodgkin lymphoma claims. See our Roundup litigation status guide.
• Hair relaxer litigation — uterine and ovarian cancer claims. See our hair relaxer lawsuit status guide.
• AFFF firefighting foam litigation — kidney, testicular and thyroid cancer claims among firefighters, veterans and exposed residents. See our AFFF lawsuit status guide.
• Paraquat litigation — Parkinson’s disease claims, which can shorten life expectancy in advanced cases. See our paraquat lawsuit status guide.
• NEC baby formula litigation — necrotizing enterocolitis in premature infants fed Similac or Enfamil preterm formula, which can be fatal. See our NEC baby formula lawsuit status guide for why federal and state court outcomes in this specific litigation have diverged so sharply.

A death connected to any of these would generally add a wrongful death and survival action to whatever product liability claim already existed against the manufacturer.

What to Preserve Immediately

• The product or its packaging, if it still exists in any form
• Complete medical records and pathology reports establishing the diagnosis and cause
• Purchase records or any documentation of product use — receipts, prescriptions, packaging
• Lot or batch information, where a prescription drug or medical device is involved and this information is available

Product evidence specifically degrades in a way medical records don’t — packaging gets discarded, and identifying which specific manufacturing batch or lot was used becomes harder the longer it goes unaddressed.

Sources & Further Reading

• Restatement (Third) of Torts: Products Liability — the standard reference on product liability doctrine, including how statutes of repose interact with latent-injury claims
• State product liability statutes of repose and any toxic-exposure or discovery-rule exceptions to them
• See our explainer on how mass tort litigation actually works, our guide to wrongful death settlement amounts for the underlying two-claims framework, and our statute of repose glossary entry for how this deadline differs from an ordinary limitations period